Atrium Therapeutics, Inc. RNA
6.92 USD -0.06 (-0.86%)
Regular-session close
6.92 0.00 0.00%
After hours · Nov 20, 4:01 PM ET
6.88 Day range 7.44
6.43 52-week range 16.54
- YTD
- -53.08%
- 1 year
- -53.08%
Held by funds
55 US ETFs and mutual funds hold RNA · largest positions
- VTI 0.00% of fund $4.29M
- NJM 0.00% of fund $3.46M
- IWM 0.00% of fund $3.10M
- FSSNX 0.01% of fund $2.05M
- VXF 0.00% of fund $1.56M
- NLO 0.01% of fund $1.20M
- IWO 0.01% of fund $822.01K
- VTWO 0.00% of fund $721.46K
- SCHA 0.00% of fund $711.46K
- FSMAX 0.00% of fund $626.67K
- MERIX 0.03% of fund $623.00K
- MOON 2.33% of fund $459.92K
- IWC 0.03% of fund $381.26K
- MDSKX 0.00% of fund $234.60K
- NAJ 0.00% of fund $227.06K
- BDSKX 0.00% of fund $214.29K
- MNTL 1.88% of fund $193.68K
- BUSM 0.14% of fund $160.00K
- FECGX 0.01% of fund $135.93K
- VITPX 0.00% of fund $122.75K
Ownership
- Institutions 0.25%
- Insiders 2.79%
- Public and other holders 97.0%
Held by insiders 2.79%
Held by institutions 0.25%
Float held by institutions 0.26%
Institutions 13
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 8.80% | 13,649,250 | 202.28M | Dec 30, 2025 |
| Blackrock Inc. | 8.28% | 12,850,801 | 190.45M | Dec 30, 2025 |
| RA Capital Management, L.P. | 5.57% | 8,641,031 | 128.06M | Dec 30, 2025 |
| Janus Henderson Group PLC | 4.47% | 6,939,503 | 102.84M | Dec 30, 2025 |
| Balyasny Asset Management LP | 3.89% | 6,040,590 | 89.52M | Dec 30, 2025 |
| Pentwater Capital Management Lp | 3.88% | 6,026,500 | 89.31M | Dec 30, 2025 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.77% | 4,303,392 | 63.78M | Sep 29, 2025 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.08% | 3,234,628 | 47.94M | Sep 29, 2025 |
| iShares Trust-iShares Russell 2000 ETF | 1.88% | 2,921,656 | 43.30M | Dec 30, 2025 |
| T. Rowe Price New Horizons Fund, Inc. | 1.69% | 2,621,852 | 38.86M | Sep 29, 2025 |
| T. Rowe Price Health Sciences Fund, Inc. | 1.63% | 2,531,865 | 37.52M | Sep 29, 2025 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund | 1.33% | 2,070,296 | 30.68M | Sep 29, 2025 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BOYCE SARAH | Chief Executive Officer | Sale | Jan 20, 2026 | 269,007 |
| CALDERARO CHARLES III | Officer | Sale | Jan 6, 2026 | 49,797 |
| FLANAGAN WILLIAM MICHAEL | Officer | Sale | Jan 20, 2026 | 85,093 |
| GALLAGHER KATHLEEN P | Officer | Stock Award(Grant) | Dec 16, 2025 | 80,838 |
| HUGHES STEVEN GEORGE | Officer | Sale | Jan 20, 2026 | 31,599 |
| LEVIN ARTHUR A. | Director | Sale | Jan 20, 2026 | 170,434 |
